๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-12-16

Study of Aspirin in Patients With Vestibular Schwannoma (NCT03079999)

Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas

๐Ÿ”ต Active, Not Recruiting Phase2 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Massachusetts Eye and Ear Infirmary

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.

Who can join: Review the eligibility criteria below.

Location: Stanford Otolaryngology/HNS โ€” Stanford, California

Age range: 12 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (5 Sites)

  • Stanford Otolaryngology/HNS โ€” Stanford, California
  • University of Miami โ€” Miami, Florida
  • Massachusetts Eye and Ear โ€” Boston, Massachusetts
  • Mayo Clinic โ€” Rochester, Minnesota
  • University of Utah โ€” Salt Lake City, Utah

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—